Genetic Studies of Insulin and Diabetes

StatusRecruiting
PhaseNot specified
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

The 50 most recent of 400 record versions are accounted for below. See every version on ClinicalTrials.gov ↗

  1. Re-verified, no change to tracked fields
  2. Minor Study description expanded, about 18 words
  3. 33 versions Re-verified since Jul 12, 2025, no change to tracked fieldsv366-v398
  4. Minor Interventions: HR-pQCT scan (Device)v365
  5. Study Status, Study Descriptionv364
  6. 13 versions Re-verified since Feb 12, 2025, no change to tracked fieldsv351-v363
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The study will allow researchers to obtain blood, plasma, DNA, and RNA for genetic studies of insulin. There will be a focus on the causes of insulin resistance and diabetes mellitus. Insulin is a hormone found in the body that controls the level of sugar in the blood. Insulin resistance refers to conditions like diabetes when insulin does not work properly. In this study researchers would like to compare patients with diabetes and other forms of insulin resistance to normal individuals. The study will investigate how insulin attaches to cells. Researchers will take 4 to 6 ounces (100-150 ml) of blood from adult patients and may request up to 12 ounces (one unit) of blood if necessary. Skin samples may be taken for a biopsy if further genetic testing is necessary. In addition some patients may be asked not to eat for up to 72 hours prior to testing.
Trial Details
NCT Number NCT00001987
Lead Sponsor National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Conditions
(from sponsor)
Diabetes Mellitus, Severe Insulin Resistance
Related terms Diabetes Mellitus, Insulin Resistance
Enrollment 1,200 participants
Start Date
Updated on ClinicalTrials.gov